Stock PROTALIX BIOTHERAPEUTICS INC
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

News Protalix Biotherapeutics Inc TEL AVIV STOCK EXCHANGE

Equities

US74365A1016

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Protalix BioTherapeutics Reports Fiscal Year 2023 Financial and Business Results
AQ
Transcript : Protalix BioTherapeutics, Inc., 2023 Earnings Call, Mar 14, 2024
Protalix BioTherapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Protalix BioTherapeutics to Announce Fiscal Year 2023 Financial and Business Results on March 14, 2024
AQ
Protalix BioTherapeutics to Participate in the 2024 BIO CEO and Investor Conference
AQ
Protalix BioTherapeutics Reports Third Quarter 2023 Financial and Business Results
AQ
Transcript : Protalix BioTherapeutics, Inc., Q3 2023 Earnings Call, Nov 06, 2023
Protalix BioTherapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
Protalix: Q3 Earnings Snapshot
AQ
Earnings Flash (PBDA) PROTALIX BIOTHERAPEUTICS Reports Q3 Revenue $10.3M
MT
Protalix BioTherapeutics to Announce Third Quarter 2023 Financial and Business Results on November 6, 2023
AQ
HC Wainwright Adjusts Protalix BioTherapeutics' Price Target to $10 From $7, Keeps Buy Rating
MT
Protalix BioTherapeutics : PLX Corporate Presentation (October 2023)
PU
Protalix BioTherapeutics Issues Statement Regarding Security Situation in Israel
AQ
Protalix BioTherapeutics Appoints Eliot Richard Forster, Ph.D. as Chairman of its Board of Directors
AQ
Protalix Biotherapeutics Appoints Eliot Richard Forster to Succeed Zeev Bronfeld as Chairman, Effective as of September 14, 2023
CI
Protalix BioTherapeutics to Present at the H.C. Wainwright 25th Annual Global Investment Conference
AQ
Protalix BioTherapeutics Reports Second Quarter 2023 Financial and Business Results
AQ
Protalix BioTherapeutics : PLX Corporate Presentation (August 2023)
PU
Transcript : Protalix BioTherapeutics, Inc., Q2 2023 Earnings Call, Aug 07, 2023
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. PLX Stock
  4. Stock
  5. News Protalix Biotherapeutics Inc